Nova Statstrip Glu-Ket
The technology used in the Nova Statstrip Glu-Ket, to measure blood glucose, has passed in a clinical validation study, in a general population, according to a recognised standard protocol, as published in a peer-reviewed publication.
|Medaval||★ Recommendation||Recent clinical validation; older protocol|
SKUP. Report from the evaluation SKUP/2013/85: StatStrip Glucose and ß-Ketone meter (Nova Biomedical), a system for blood glucose measurement. Uppsala, Sweden: SKUP; 2013. 83 p. Available from: skup.org.
15197:2003 - Pass Arterial samples from adult intensive-care patients (Note: BLS-recorded measurements)
15197:2003 Venous neonatal samples (Note: Midwife-recorded measurements)
15197:2003 - Fail Capillary adult samples (Note: Nurse-recorded measurements)
Ceriotti F, Kaczmarek E, Guerra E, Mastrantonio F, Lucarelli F, Valgimigli F, Mosca A. Comparative performance assessment of point-of-care testing devices for measuring glucose and ketones at the patient bedside. J Diabetes Sci Technol. 2015 Mar;9(2):268-77. Epub: 2014 Dec 17. doi: 10.1177/1932296814563351. PMID: 25519295. Available from: PMC4604596.
The publication evaluates the performance of the Nova Statstrip Glu-Ket, though not in a formal validation.
The interferences assessed included acetoacetate, acetaminophen, ascorbic acid, galactose, maltose, uric acid, and sodium. StatStrip ketone and glucose measurements were unaffected by the interferences tested with exception of ascorbic acid, which reduced the higher level ketone value.